Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-059804)

Filing Details

Accession Number:: 0001209191-21-059804
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-10-06 16:00:18
Reporting Period:: 2021-10-04

Accepted Time:: 2021-10-06 16:00:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1654151	Deciphera Pharmaceuticals Inc.	DCPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1325710	L Matthew Sherman	C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451	Evp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-10-04	2,659	$33.17	46,029	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was to cover tax liabilities in the vesting of restricted stock.
Includes 302 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 14, 2021.